In Lysando’s Artilysin tech, AiCuris sees means to evade antibiotic resistance

AiCuris believes it can bypass antibiotic resistance by using Lysando's platform to develop an array of phage-derived antibacterial proteins spanning broad and narrow

Read the full 238 word article

User Sign In